Clinical Trial: The Safety and Efficacy of Allogeneic CD70 CAR-T Therapy in Unresectable or Metastatic Clear Cell Renal Cell Carcinoma

U.S., June 13 -- ClinicalTrials.gov registry received information related to the study (NCT07645690) titled 'The Safety and Efficacy of Allogeneic CD70 CAR-T Therapy in Unresectable or Metastatic Clear Cell Renal Cell Carcinoma' on June 09.

Brief Summary: CLEAR CAR-T cell injection (ET-970) is an engineered CD70-targeting allogeneic Chimeric Antigen Receptor T-Cell (CAR-T cell). This is a multi-center, single-arm, open-label, early exploratory clinical study. The objective of this study is to evaluate the safety and preliminary efficacy of ET-970 in unresectable or metastatic clear cell renal cell carcinoma.

Study Start Date: July 01

Study Type: INTERVENTIONAL

Condition: Unresectable or Metastatic Clear Cell Renal Cell Carcinoma

Inter...